Global Contraceptive Drugs Market to Reach US$ 20,200.5 Mn, Rising Incidence of Unwanted Pregnancies Guarantees Growth | Fortune Business Insights

The rising prevalence of unwanted pregnancies is boosting the global contraceptive drugs market. In a report, titled "Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025" Fortune Business Insights identifies various factors enabling growth in the market.

According to the report, the global contraceptive drugs market is anticipated to rise at 5.8% CAGR and reach a value of US$ 20,200.5 Mn by 2025 from US$ 13,097.7 Mn in 2017. Remarkably improving access to contraceptive pills around the world is a key factor propelling growth in this market.

Key Development:

February 2020: Agile Therapeutics announced received U.S. FDA approval for Twirla (levonorgestrel and ethinyl estradiol), a contraceptive transdermal patch for woman.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-drugs-market-100063

Drivers & Restraints:

Increasing Health and Sexual Wellness Plans to Augment Growth

Non-profit groups and regional and national healthcare authorities are increasingly focusing on improving women's health and sexual well-being. These organizations promote the use of contraceptives and raise public awareness about various methods of contraception through various campaigns and public awareness activities. This, together with the rising number of goods put into the market by major global and domestic companies, is propelling the contraceptive drugs market growth. The major reason boosting the worldwide market's growth is the increasing attention of leading industry players and healthcare authorities on generating awareness through public initiatives in order to extend access to contraceptives. Furthermore, government organizations in developing nations are encouraging the use and acceptance of contraceptive medicines to reduce population growth and undesired pregnancies among adults. For example, Ireland's government stated in December 2020 that it will provide free contraception to women aged 17 to 25.

Market Segments:

Based on product, the global market for contraceptive drugs is segmented into oral, injectable, and patches. The oral segment is further categorized into combined contraceptives, and progestin-only pills. The global market is classified into hospital pharmacy, retail pharmacy, clinics, online channel, public channel & NGOs, and others based on distribution channels. Geographically, the market is categorized into Asia Pacific, Europe, Latin America, North America, and the Middle East & Africa.

Quick Buy - Contraceptive Drugs Market

https://www.fortunebusinessinsights.com/checkout-page/100063

What are the Report Highlights?

The report offers a comprehensive overview of the market and emphasizes factors propelling, repelling, obstructing, and creating opportunities for the market. It also throws light on the table of segmentation, the list of leading segments with figures, and their attributed factors. The report also discusses the market's competitive landscape, the list of significant players, and the key strategies adopted to gain a competitive edge in the conveyor systems market. Besides this, the report highlights the major industry developments of the market, current market trends, and other interesting insights into the market.

Regional Insights:

Increasing Number of Childbearing Population to Foster Growth in North America

In 2020, the contraceptive medicines industry in North America will be worth USD 6.56 billion. North America's supremacy in 2020 will be attributed to a high level of contraceptive awareness among the population and an increasing number of childbearing women and a low fertility rate in the region. Contraceptive use is greater in North America, according to research issued by the United Nations. Around 62 percent of women aged 15 to 49 in the U.S. use some kind of contraception, with more than 13 percent of these women using oral contraceptives. In the global market, Europe held the second-largest contraceptive drugs market share. This can be linked to Europe's rising childbearing population as well as robust contraception reimbursement regulations.

Competitive Landscape:

Product Launches by Prominent Companies to Consolidate Business

The market is fragmented, with a small number of multinational companies and many local generic medicine producers. To obtain a competitive advantage over other competitors, the market's top players rely on research and development and strategic alliances. For example, Bayer AG stated in January 2020 that it had reached a deal with Daré Bioscience, Inc. to sell Daré's experimental contraceptive medicine in the U.S. upon FDA clearance.

Get your Customized Research Report:

https://www.fortunebusinessinsights.com/enquiry/customization/contraceptive-drugs-market-100063

The Report Lists the Key Companies in the Market:

Piramal Enterprises Ltd. (Mumbai, India)
Agile Therapeutics (New Jersey, U.S.)
Janssen Global Services, LLC (Raritan, New Jersey, U.S.)
AbbVie Inc. (Lake Bluff, U.S.)
Pfizer Inc. (New York, U.S.)
Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)
Viatris Inc. (Canonsburg, U.S.)
Amneal Pharmaceuticals, Inc. (Bridgewater Township, U.S.)
Bayer AG (Leverkusen, Germany)
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/contraceptive-drugs-market-100063

Table of Content

Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Total Fertility Rate, Key Countries, 2019
Penetration of Oral Contraceptive Pills
Penetration of Injectable Contraceptives
Pipeline Analysis
New Product Launches
Regulatory Scenario - Contraceptive Drugs Market
Recent Industry Developments (Mergers, Acquisitions, etc.)
Impact of COVID-19 on the Market
Global Contraceptive Drugs Market Analysis, Insights and Forecast, 2017-2028
Key Findings / Summary
Market Analysis, Insights and Forecast - By Product
Oral
Combined Contraceptives
Progestin-only Pills
Injectable
Patches
Market Analysis, Insights and Forecast - By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channel
Public Channel & NGOs
Others
Market Analysis, Insights and Forecast - By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
ToC Continue…!

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

This release was published on openPR.